UbiVac's Debt Round

UbiVac raised a round of funding on August 04, 2017.

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer and infectious diseases.…

Articles about UbiVac's Debt Round: